# AKCCHF grant #00982 (closed)

Evaluation of Efficacy of Fasaret in Dogs with Osteosarcoma

Don Bellgrau, PhD, ApopLogic Pharmaceuticals LLC

**[Final Report](/files/AKCCHF%20grant%2001584%20MY4%20FINAL%20Summary.pdf)**

**Publication:**

Modiano JF, Bellgrau et al. [Inflammation, Apoptosis, and Necrosis Induced by Neoadjuvant Fas Ligand Gene Therapy Improves Survival ofDogs With Spontaneous Bone Cancer.](http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3519983/) 2012. Molecular Therapy 20: 2234-2243.
